Documents

Ideas Discussions Technicals Forecast Seasonals

Vivos Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Vivos Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 19, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 15, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 31, 2025

Transcript

Earnings release8-K

Annual report10-K

Q3 2024

Nov 14, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 14, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 28, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 14, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 16, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

Jun 08, 2023

Quarterly report10-Q

2022

Q4 2022

Mar 30, 2023

Annual report10-K

Earnings release8-K

Q2 & Q3 2022

Dec 20, 2022

Quarterly report10-Q

Q1 2022

May 16, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 31, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 15, 2021

Quarterly report10-Q

Q2 2021

Aug 12, 2021

Quarterly report10-Q

Q1 2021

May 17, 2021

Quarterly report10-Q

2020

Q4 2020

Mar 25, 2021

Annual report10-K